BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21180591)

  • 1. Oral proton-pump inhibitors and step-down therapy for nonulcer dyspepsia: is this the right approach?
    Waldum HL; Martinsen TC; Hauso O; Qvigstad G
    Therap Adv Gastroenterol; 2010 Mar; 3(2):73-6. PubMed ID: 21180591
    [No Abstract]   [Full Text] [Related]  

  • 2. The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis.
    Moayyedi P; Delaney BC; Vakil N; Forman D; Talley NJ
    Gastroenterology; 2004 Nov; 127(5):1329-37. PubMed ID: 15521002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonulcer dyspepsia and proton pump inhibitors.
    Waldum HL; Martinsen TC; Brenna E
    Gastroenterology; 2005 Mar; 128(3):805; author reply 805-6. PubMed ID: 15765429
    [No Abstract]   [Full Text] [Related]  

  • 4. Is nonulcer dyspepsia related to Helicobacter pylori infection?
    Fennerty MB
    Semin Gastrointest Dis; 2001 Jul; 12(3):180-5. PubMed ID: 11478750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonulcer Dyspepsia.
    Boeckxstaens GE
    Curr Treat Options Gastroenterol; 2001 Aug; 4(4):317-322. PubMed ID: 11469990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial.
    van Marrewijk CJ; Mujakovic S; Fransen GA; Numans ME; de Wit NJ; Muris JW; van Oijen MG; Jansen JB; Grobbee DE; Knottnerus JA; Laheij RJ
    Lancet; 2009 Jan; 373(9659):215-25. PubMed ID: 19150702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stepwise diagnosis and treatment from uninvestigated dyspepsia to functional dyspepsia in clinical practice in Japan: proposal of a 4-step algorithm.
    Nakajima S
    Digestion; 2009; 79 Suppl 1():19-25. PubMed ID: 19153486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter double-blind study of sulglycotide versus sucralfate in nonulcer dyspepsia.
    Psilogenis M; Nazzari M; Ferrari PA
    Int J Clin Pharmacol Ther Toxicol; 1990 Sep; 28(9):369-74. PubMed ID: 2228322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review: proton-pump inhibitors alleviate symptoms of functional (nonulcer) dyspepsia but may not be better than H2-antagonists.
    Schwartz M
    ACP J Club; 2002; 137(2):54. PubMed ID: 12207432
    [No Abstract]   [Full Text] [Related]  

  • 10. Low yield of endoscopy in patients with persistent dyspepsia taking proton pump inhibitors.
    Smith T; Verzola E; Mertz H
    Gastrointest Endosc; 2003 Jul; 58(1):9-13. PubMed ID: 12838213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews.
    Moayyedi P; Deeks J; Talley NJ; Delaney B; Forman D
    Am J Gastroenterol; 2003 Dec; 98(12):2621-6. PubMed ID: 14687807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric emptying rate of solids in patients with nonulcer dyspepsia.
    Maes BD; Ghoos YF; Hiele MI; Rutgeerts PJ
    Dig Dis Sci; 1997 Jun; 42(6):1158-62. PubMed ID: 9201077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal gastric acid secretion in nonulcer dyspepsia with or without duodenitis.
    Collen MJ; Loebenberg MJ
    Dig Dis Sci; 1989 Feb; 34(2):246-50. PubMed ID: 2914546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review: proton-pump inhibitor therapy reduces symptoms in nonulcer dyspepsia better than placebo.
    Veldhuyzen Van Zanten SJ
    ACP J Club; 2005; 142(3):74. PubMed ID: 15862073
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of coffee intake and coffee-induced symptoms in patients with duodenal ulcer, nonulcer dyspepsia, and normal controls.
    Elta GH; Behler EM; Colturi TJ
    Am J Gastroenterol; 1990 Oct; 85(10):1339-42. PubMed ID: 2220726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of Helicobacter pylori in nonulcer dyspepsia. Importance of stratification according to age.
    Greenberg RE; Bank S
    Arch Intern Med; 1990 Oct; 150(10):2053-5. PubMed ID: 2222090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials.
    Laine L; Schoenfeld P; Fennerty MB
    Ann Intern Med; 2001 Mar; 134(5):361-9. PubMed ID: 11242496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyspepsia is associated with CagA-positive Helicobacter pylori.
    Nelson DB; Murdoch M; Sandozi IK; Dalmasso AP; Crabtree JE; Ho SB
    Am J Gastroenterol; 2000 Dec; 95(12):3412-7. PubMed ID: 11151870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome.
    Talley NJ; Phillips SF; Bruce B; Twomey CK; Zinsmeister AR; Melton LJ
    Gastroenterology; 1990 Aug; 99(2):327-33. PubMed ID: 2365186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Helicobacter pylori in nonulcer dyspepsia. A debate--against.
    Talley NJ
    Gastroenterol Clin North Am; 1993 Mar; 22(1):153-67. PubMed ID: 8449564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.